News & Announcements

Weil Serves as Antitrust Counsel to Johnson & Johnson in the Sale of its Cordis Unit to Cardinal Health

Weil’s Antitrust team is representing Johnson & Johnson in the recently announced sale of its Cordis business to Cardinal Health, a transaction valued at $1.99 billion. The transaction is subject to antitrust regulatory approval as well as customary closing conditions, and is expected to close toward the end of 2015. Cordis is a leading developer and manufacturer of interventional cardiology and endovascular devices.

Weil’s Antitrust team includes partners Steven Newborn and Steven Bernstein, counsel Vadim Brusser, and associate Benjamin Bauer.